Asthma and lung disease treatment firm Vectura is to collaborate with a US tech firm to develop a range of innovative inhalers. The Chippenham firm, which makes inhalable dry-powder drugs that treat lung conditions such as asthma, emphysema and chronic bronchitis, has agreed a partnership with Propeller Health to use its intelligent sensor technology....